Skip to main content
Skip to Footer

American Journal of Psychiatry

  • Volume 162
  • Number 1
  • January 2005

In This Issue

Editorial

Reviews and Overviews

Publication date: 01 January 2005

Pages3–11

Psychiatric genetics, which is growing in size and influence within psychiatry, employs four major research paradigms: 1) basic genetic epidemiology, 2) advanced genetic epidemiology, 3) gene finding methods, and 4) molecular genetics. Paradigms 1 and 2 ...

https://doi.org/10.1176/appi.ajp.162.1.3

Publication date: 01 January 2005

Pages12–24

OBJECTIVE: The authors synthesize findings of previous studies implicating migration as a risk factor for the development of schizophrenia and provide a quantitative index of the associated effect size. METHOD: MEDLINE was searched for population-based ...

https://doi.org/10.1176/appi.ajp.162.1.12

Images in Neuroscience

Introspections

Clinical Case Conference

Images in Psychiatry

Article

Publication date: 01 January 2005

Pages43–49

OBJECTIVE: People with schizophrenia, schizoaffective disorder, and bipolar illness share clinical symptoms, biological findings, and genetic susceptibility. Diminished suppression of the P50 auditory evoked potential is a phenotype used in studies of ...

https://doi.org/10.1176/appi.ajp.162.1.43

Publication date: 01 January 2005

Pages50–57

OBJECTIVE: The authors investigated sleep-related functioning in euthymic patients with bipolar disorder. METHOD: Euthymic patients with bipolar disorder (N=20), patients with insomnia (N=20), and subjects with good sleep (N=20) were compared on data from ...

https://doi.org/10.1176/appi.ajp.162.1.50

Publication date: 01 January 2005

Pages58–64

OBJECTIVE: The purpose of this study was to determine whether adjunctive use of a psychostimulant (mixed amphetamine salts) was safe and efficacious for treatment of symptoms of attention deficit hyperactivity disorder (ADHD) in pediatric outpatients with ...

https://doi.org/10.1176/appi.ajp.162.1.58

Publication date: 01 January 2005

Pages79–91

OBJECTIVE: This study ascertained the incidence of complications during pregnancy, labor, and delivery and the neonatal characteristics of infants born to women with schizophrenia, bipolar disorder, or major depression in a population-based cohort. METHOD:...

https://doi.org/10.1176/appi.ajp.162.1.79

Publication date: 01 January 2005

Pages92–101

OBJECTIVE: Blunted affect is a major symptom in schizophrenia, and affective deficits clinically encompass deficits in expressiveness. Emotion research and ethological studies have shown that patients with schizophrenia are impaired in various modalities ...

https://doi.org/10.1176/appi.ajp.162.1.92

Publication date: 01 January 2005

Pages102–109

OBJECTIVE: The authors compared the patterns and specificity of premorbid personality dimensions in first-episode schizophrenia patients with those in patients with first-episode nonschizophrenia psychoses and healthy comparison subjects. METHOD: A series ...

https://doi.org/10.1176/appi.ajp.162.1.102

Publication date: 01 January 2005

Pages110–117

OBJECTIVE: It is important to understand the stability of cognitive performance in schizophrenia in order to understand 1) the potential improvements in performance associated with the beneficial effects of cognitive-enhancing medications and 2) the ...

https://doi.org/10.1176/appi.ajp.162.1.110

Publication date: 01 January 2005

Pages118–123

OBJECTIVE: Weight gain is a commonly observed adverse effect of atypical antipsychotic medications, but associated changes in energy balance and body composition are not well defined. The authors report here the effect of olanzapine on body weight, body ...

https://doi.org/10.1176/appi.ajp.162.1.118

Publication date: 01 January 2005

Pages124–129

OBJECTIVE: Olanzapine has been hypothesized to have superior efficacy in patients with treatment-resistant schizophrenia. The authors examined the comparative efficacy and safety of olanzapine and haloperidol in outpatients with partially responsive ...

https://doi.org/10.1176/appi.ajp.162.1.124

Publication date: 01 January 2005

Pages130–136

OBJECTIVE: The authors evaluated the efficacy and safety of augmenting clozapine with risperidone in patients with treatment-resistant schizophrenia. METHOD: In a randomized, double-blind, placebo-controlled 12-week trial, 40 patients unresponsive or ...

https://doi.org/10.1176/appi.ajp.162.1.130

Publication date: 01 January 2005

Pages137–145

OBJECTIVE: Selective serotonin reuptake inhibitors may be effective for some patients with pathological gambling, but those with comorbid conditions, such as bipolar spectrum disorders, may relapse during treatment. To the authors’ knowledge, this is the ...

https://doi.org/10.1176/appi.ajp.162.1.137

Publication date: 01 January 2005

Pages146–150

OBJECTIVE: Anxiety disorders are highly prevalent in elderly persons. However, to date, the efficacy of selective serotonin reuptake inhibitors (SSRIs) for the treatment of anxiety disorders in this age group has not been established. METHOD: Thirty-four ...

https://doi.org/10.1176/appi.ajp.162.1.146

Publication date: 01 January 2005

Pages162–167

OBJECTIVE: Osteoporosis is regularly mentioned as a possible consequence of treatment with prolactin-increasing antipsychotic medications, but little is known about the prevalence and the degree of loss of bone mineral density in patients suffering from ...

https://doi.org/10.1176/appi.ajp.162.1.162

Publication date: 01 January 2005

Pages168–174

OBJECTIVE: The pathogenesis of bone loss in major depressive disorder is a matter of debate. Studies of bone loss in nonpsychiatric medical disorders have found an association between the activation of osteoclastic cells and an imbalance of pro- and ...

https://doi.org/10.1176/appi.ajp.162.1.168

Brief Report

Publication date: 01 January 2005

Pages175–177

OBJECTIVE: Depression has been associated with increases in circulating cytokines in younger adults, and there is evidence for prefrontal inflammation in late-life depression. The authors tested the hypothesis that levels of cytokine interleukin-1β (IL-1β)...

https://doi.org/10.1176/appi.ajp.162.1.175

Publication date: 01 January 2005

Pages178–180

OBJECTIVE: The impact of depression and perceived loneliness in the oldest old is largely unknown. The authors studied the relationship between the presence of depressive symptoms and all-cause mortality in old age, especially the potential distorting ...

https://doi.org/10.1176/appi.ajp.162.1.178

Publication date: 01 January 2005

Pages181–183

OBJECTIVE: This article describes pilot testing of interpersonal psychotherapy adapted for posttraumatic stress disorder (PTSD). Unlike most psychotherapies for PTSD, interpersonal psychotherapy is not exposure-based, focusing instead on interpersonal ...

https://doi.org/10.1176/appi.ajp.162.1.181

Publication date: 01 January 2005

Pages184–186

OBJECTIVE: This pilot study tests the usefulness of the Treatment Initiation Program (TIP) to improve depression in older adults. The TIP is an individualized, early intervention to address older adults’ attitudes (e.g., perceived need for care and stigma)...

https://doi.org/10.1176/appi.ajp.162.1.184

Publication date: 01 January 2005

Pages186–188

OBJECTIVE: This study evaluated a brief educational video designed to enhance the informed consent process for people with serious mental and medical illnesses who are considering participating in treatment research. METHOD: Individuals with schizophrenia ...

https://doi.org/10.1176/appi.ajp.162.1.186

Publication date: 01 January 2005

Pages189–191

OBJECTIVE: As part of a synthesis of evidence regarding the efficacy and safety of ephedra, the authors describe data on psychiatric adverse events from reports submitted to the Food and Drug Administration (FDA). METHOD: The authors reviewed all 1,820 ...

https://doi.org/10.1176/appi.ajp.162.1.189

Letter to the Editor

Book Forum: Childhood Disorders

Book Forum: Thinking About the Future

Book Forum: Cognitive Impairment

Book Forum: Anxiety Disorders

Book Forum: Compulsive Disorders and Eating Disorders

Book Forum: History of Psychoanalysis and Psychiatry

Disclosure

Past Issues

View Issues Archive
No.11
View Issue
1 Nov 2024

Vol. 181 | No. 11

No.10
View Issue
1 Oct 2024

Vol. 181 | No. 10

No.9
View Issue
1 Sep 2024

Vol. 181 | No. 9

No.8
View Issue
1 Aug 2024

Vol. 181 | No. 8